Varicella pneumonia in a bone marrow-transplanted, immune-reconstituted adenosine deaminase-deficient patient with severe combined immunodeficiency disease
- PMID: 2989324
- DOI: 10.1007/BF00915509
Varicella pneumonia in a bone marrow-transplanted, immune-reconstituted adenosine deaminase-deficient patient with severe combined immunodeficiency disease
Abstract
Bone marrow transplantation provides an important modality for "enzyme replacement" and the immune reconstitution of patients with adenosine deaminase (ADA) deficiency and severe combined immunodeficiency disease. We report a patient with ADA deficiency who develops severe varicella pneumonia 6 years after successful bone marrow transplantation and immune reconstitution. Marked abnormalities in T-cell mitogen responsiveness and pokeweed mitogen-induced polyclonal immunoglobulin synthesis occurred. Coculture experiments suggested the presence of increased suppressor activity. T-cell phenotyping showed decreased T3 and T4 subsets. These abnormalities slowly resolved over several months as the patient recovered from the varicella infection. ADA enzyme levels and metabolite concentrations in urine and erythrocytes remained unchanged. These findings, together with the chromosome and immune studies, suggested that the bone marrow graft remained intact. These studies indicate that immunologically reconstituted ADA-deficient patients may be at higher risk for complications related to varicella infection and suggest that the institution of preventive measures is important.
Similar articles
-
Reconstitution of T- and B-cell function after T-lymphocyte-depleted haploidentical bone marrow transplantation in severe combined immunodeficiency due to adenosine deaminase deficiency.Clin Immunol Immunopathol. 1987 Sep;44(3):317-20. doi: 10.1016/0090-1229(87)90075-4. Clin Immunol Immunopathol. 1987. PMID: 3304740
-
HLA-haploidentical bone marrow transplantation in three infants with adenosine deaminase deficiency: stable immunological reconstitution and reversal of skeletal abnormalities.Eur J Pediatr. 1989 Nov;149(2):104-9. doi: 10.1007/BF01995857. Eur J Pediatr. 1989. PMID: 2591400
-
Rejection of bone marrow transplant and resistance of alloantigen reactive cells to in vivo deoxyadenosine in adenosine deaminase deficiency.Clin Immunol Immunopathol. 1988 Nov;49(2):242-50. doi: 10.1016/0090-1229(88)90114-6. Clin Immunol Immunopathol. 1988. PMID: 2971490
-
ADA and PNP deficiencies: how it all began.Ann N Y Acad Sci. 1985;451:1-8. doi: 10.1111/j.1749-6632.1985.tb27090.x. Ann N Y Acad Sci. 1985. PMID: 3935025 Review. No abstract available.
-
Therapy in adenosine deaminase and purine nucleoside phosphorylase deficient patients.Clin Biochem. 1983 Feb;16(1):43-7. doi: 10.1016/s0009-9120(83)94381-3. Clin Biochem. 1983. PMID: 6407780 Review.
Cited by
-
The effects of retinoic acid on immunoglobulin synthesis: role of interleukin 6.J Clin Immunol. 1996 May;16(3):171-9. doi: 10.1007/BF01540916. J Clin Immunol. 1996. PMID: 8734361
-
Corticosteroids Contribute to Serious Adverse Events Following Live Attenuated Varicella Vaccination and Live Attenuated Zoster Vaccination.Vaccines (Basel). 2021 Jan 6;9(1):23. doi: 10.3390/vaccines9010023. Vaccines (Basel). 2021. PMID: 33418856 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical
Research Materials